|
FY2025
12 months to Nov 1, 2025
|
FY2024
12 months to Nov 2, 2024
|
FY2023
12 months to Oct 28, 2023
|
FY2022
12 months to Oct 29, 2022
|
FY2021
12 months to Oct 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | |||||
| Costs and Expenses | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, marketing, general and administrative | |||||
| Amortization of intangibles | |||||
| Special charges, net | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Nonoperating expense (income): | |||||
| Loss on extinguishment of debt | |||||
| Interest expense | |||||
| Interest income | |||||
| Other, net | |||||
| Total nonoperating expense (income) | |||||
| Earnings | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Shares used to compute earnings per common share — basic (in shares) | |||||
| Shares used to compute earnings per common share — diluted (in shares) | |||||
| Basic earnings per common share (in dollars per share) | |||||
| Diluted earnings per common share (in dollars per share) | |||||
Loading...
